Literature DB >> 21915140

Insights into autotaxin: how to produce and present a lipid mediator.

Wouter H Moolenaar1, Anastassis Perrakis.   

Abstract

Autotaxin (ATX) is a secreted phosphodiesterase that produces the lipid mediator lysophosphatidic acid (LPA). LPA acts through specific guanine-nucleotide-binding protein (G protein)-coupled receptors to stimulate migration, proliferation, survival and other functions in many cell types. ATX is important in vivo for processes as diverse as vasculogenesis, lymphocyte trafficking and tumour progression. However, the inner workings of ATX have long been elusive, in terms of both its substrate specificity and how localized LPA signalling is achieved. Structural studies have shown how ATX recognizes its substrates and may interact with the cell surface to promote specificity in LPA signalling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21915140     DOI: 10.1038/nrm3188

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  61 in total

1.  Pro-inflammatory secretory phospholipase A2 type IIA binds to integrins alphavbeta3 and alpha4beta1 and induces proliferation of monocytic cells in an integrin-dependent manner.

Authors:  Jun Saegusa; Nobuaki Akakura; Chun-Yi Wu; Case Hoogland; Zi Ma; Kit S Lam; Fu-Tong Liu; Yoko K Takada; Yoshikazu Takada
Journal:  J Biol Chem       Date:  2008-07-17       Impact factor: 5.157

2.  Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate.

Authors:  Laurens A van Meeteren; Paula Ruurs; Evangelos Christodoulou; James W Goding; Hideo Takakusa; Kazuya Kikuchi; Anastassis Perrakis; Tetsuo Nagano; Wouter H Moolenaar
Journal:  J Biol Chem       Date:  2005-03-15       Impact factor: 5.157

3.  Kinetic analysis of autotaxin reveals substrate-specific catalytic pathways and a mechanism for lysophosphatidic acid distribution.

Authors:  Lauren P Saunders; Wenxiang Cao; William C Chang; Ronald A Albright; Demetrios T Braddock; Enrique M De La Cruz
Journal:  J Biol Chem       Date:  2011-06-30       Impact factor: 5.157

4.  Biochemical and molecular characterization of a novel choline-specific glycerophosphodiester phosphodiesterase belonging to the nucleotide pyrophosphatase/phosphodiesterase family.

Authors:  Hideki Sakagami; Junken Aoki; Yumiko Natori; Kiyotaka Nishikawa; Yoshiyuki Kakehi; Yasuhiro Natori; Hiroyuki Arai
Journal:  J Biol Chem       Date:  2005-03-23       Impact factor: 5.157

5.  Lysophosphatidic acid induces neuronal shape changes via a novel, receptor-mediated signaling pathway: similarity to thrombin action.

Authors:  K Jalink; T Eichholtz; F R Postma; E J van Corven; W H Moolenaar
Journal:  Cell Growth Differ       Date:  1993-04

Review 6.  Phosphatase-resistant analogues of lysophosphatidic acid: agonists promote healing, antagonists and autotaxin inhibitors treat cancer.

Authors:  Glenn D Prestwich; Joanna Gajewiak; Honglu Zhang; Xiaoyu Xu; Guanghui Yang; Monica Serban
Journal:  Biochim Biophys Acta       Date:  2008-04-08

7.  Lysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure.

Authors:  Manikandan Panchatcharam; Sumitra Miriyala; Fanmuyi Yang; Mauricio Rojas; Christopher End; Christopher Vallant; Anping Dong; Kevin Lynch; Jerold Chun; Andrew J Morris; Susan S Smyth
Journal:  Circ Res       Date:  2008-08-14       Impact factor: 17.367

8.  The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak.

Authors:  Andrew M Tager; Peter LaCamera; Barry S Shea; Gabriele S Campanella; Moisés Selman; Zhenwen Zhao; Vasiliy Polosukhin; John Wain; Banu A Karimi-Shah; Nancy D Kim; William K Hart; Annie Pardo; Timothy S Blackwell; Yan Xu; Jerold Chun; Andrew D Luster
Journal:  Nat Med       Date:  2007-12-09       Impact factor: 53.440

9.  Serum-induced membrane depolarization in quiescent fibroblasts: activation of a chloride conductance through the G protein-coupled LPA receptor.

Authors:  F R Postma; K Jalink; T Hengeveld; A G Bot; J Alblas; H R de Jonge; W H Moolenaar
Journal:  EMBO J       Date:  1996-01-02       Impact factor: 11.598

10.  Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass.

Authors:  Isabelle Gennero; Sara Laurencin-Dalicieux; Françoise Conte-Auriol; Fabienne Briand-Mésange; Danielle Laurencin; Jackie Rue; Nicolas Beton; Nicole Malet; Marianne Mus; Akira Tokumura; Philippe Bourin; Laurence Vico; Gérard Brunel; Richard O C Oreffo; Jerold Chun; Jean Pierre Salles
Journal:  Bone       Date:  2011-05-01       Impact factor: 4.398

View more
  62 in total

1.  Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders.

Authors:  Jerold Chun; Yasuyuki Kihara; Deepa Jonnalagadda; Victoria A Blaho
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-01-06       Impact factor: 13.820

2.  Metabolite Signatures of Metabolic Risk Factors and their Longitudinal Changes.

Authors:  Xiaoyan Yin; Subha Subramanian; Christine M Willinger; George Chen; Peter Juhasz; Paul Courchesne; Brian H Chen; Xiaohang Li; Shih-Jen Hwang; Caroline S Fox; Christopher J O'Donnell; Pieter Muntendam; Valentin Fuster; Ivana Bobeldijk-Pastorova; Silvia C Sookoian; Carlos J Pirola; Neal Gordon; Aram Adourian; Martin G Larson; Daniel Levy
Journal:  J Clin Endocrinol Metab       Date:  2016-02-23       Impact factor: 5.958

3.  Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.

Authors:  Shannon K Oda; Pamela Strauch; Yuko Fujiwara; Amin Al-Shami; Tamas Oravecz; Gabor Tigyi; Roberta Pelanda; Raul M Torres
Journal:  Cancer Immunol Res       Date:  2013-10       Impact factor: 11.151

4.  Autotaxin-mediated lipid signaling intersects with LIF and BMP signaling to promote the naive pluripotency transcription factor program.

Authors:  Cody Kime; Masayo Sakaki-Yumoto; Leeanne Goodrich; Yohei Hayashi; Salma Sami; Rik Derynck; Michio Asahi; Barbara Panning; Shinya Yamanaka; Kiichiro Tomoda
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-13       Impact factor: 11.205

Review 5.  Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression.

Authors:  Lorenzo Federico; Kang Jin Jeong; Christopher P Vellano; Gordon B Mills
Journal:  J Lipid Res       Date:  2015-05-14       Impact factor: 5.922

6.  SnapShot: Bioactive lysophospholipids.

Authors:  Wouter H Moolenaar; Timothy Hla
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

7.  LPA1 receptor-mediated thromboxane A2 release is responsible for lysophosphatidic acid-induced vascular smooth muscle contraction.

Authors:  Péter Tibor Dancs; Éva Ruisanchez; Andrea Balogh; Cecília Rita Panta; Zsuzsanna Miklós; Rolf M Nüsing; Junken Aoki; Jerold Chun; Stefan Offermanns; Gábor Tigyi; Zoltán Benyó
Journal:  FASEB J       Date:  2017-01-09       Impact factor: 5.191

Review 8.  Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma.

Authors:  Ponugoti Vasantha Rao
Journal:  J Ocul Pharmacol Ther       Date:  2013-11-27       Impact factor: 2.671

9.  The polybasic insertion in autotaxin α confers specific binding to heparin and cell surface heparan sulfate proteoglycans.

Authors:  Anna J S Houben; Xander M R van Wijk; Laurens A van Meeteren; Leonie van Zeijl; Els M A van de Westerlo; Jens Hausmann; Alexander Fish; Anastassis Perrakis; Toin H van Kuppevelt; Wouter H Moolenaar
Journal:  J Biol Chem       Date:  2012-11-13       Impact factor: 5.157

Review 10.  Autotaxin: structure-function and signaling.

Authors:  Anastassis Perrakis; Wouter H Moolenaar
Journal:  J Lipid Res       Date:  2014-02-18       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.